VenoStent
About:
VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.
Website: http://www.venostent.com
Twitter/X: venostent
Top Investors: Alumni Ventures, National Science Foundation, Y Combinator, Norwest Venture Partners, National Institutes of Health
Description:
VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year. The company's technology is made from a new class of shape-memory polymers that are primarily used as an external stent in coronary artery bypass surgery and do not require sutures, allowing doctors to reduce surgery time, infection risk, and wound resuming in hemodialysis patients while also reducing failure from vein occlusion.
$29.8M
$1M to $10M
Houston, Texas, United States
2017-01-01
Geoffrey Lucks, Tim Boire
11-50
2024-06-27
Private
© 2025 bioDAO.ai